However, the GLP-1 saga turns out, the fact that these drugs have popped up seemingly out of nowhere, and have generated such excitement, highlights the potential existing in the huge repurposed drug (drugs used in another condition than for which they are approved) market for these diseases
This can cause problems like fatigue, hair loss, or muscle weakness
To advance personalized treatment strategies, it is critical to improve current understanding of the overlapping pathophysiology as well as the heterogeneity of obesity and diabetes, including their multi-hormonal dysregulation and inter-individual differences [24, 25]
they just dont necessarily want to admit it
Expect some GI adjustment but potentially less severe than a completely naive start